Yin, Hui

Pioglitazone use and risk of bladder cancer: Population based cohort study

Tuccori, M., Filion, K. B., Yin, H., Yu, O. H., Platt, R. W., & Azoulay, L. (2016) · BMJ

Metabolism, Diabetes, and CancerBladder and Urothelial Cancer Treatments

Cited by 237

Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

Simms-Williams, N., Treves, N., Yin, H., Lu, S., Yu, O., Pradhan, R., Renoux, C., Suissa, S., & Azoulay, L. (2024) · BMJ

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 151

Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus.

Faillie, J.-L., Yu, O. H., Yin, H., Hillaire-Buys, D., Barkun, A., & Azoulay, L. (2016) · JAMA Internal Medicine

Diabetes Treatment and ManagementGallbladder and Bile Duct Disorders

Cited by 134

Glucagon-like peptide 1 receptor agonists and the risk of incident diabetic retinopathy

Douros, A., Filion, K. B., Yin, H., Yu, O. H., Etminan, M., Udell, J. A., & Azoulay, L. (2018) · Diabetes Care

Diabetes Treatment and ManagementRetinal Diseases and Treatments

Cited by 70

Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes

Faillie, J., Yin, H., Yu, O. H. Y., Herrero, A., Altwegg, R., Renoux, C., & Azoulay, L. (2022) · Clinical Pharmacology & Therapeutics

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 67

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

Shapiro, S. B., Yin, H., Yu, O. H. Y., Rej, S., Suissa, S., & Azoulay, L. (2025) · BMJ

Diabetes Treatment and ManagementSuicide and Self-Harm Studies

Cited by 49

Tramadol for noncancer pain and the risk of hyponatremia

Fournier, J.-P., Yin, H., Nessim, S. J., Montastruc, J.-L., & Azoulay, L. (2015) · The American Journal of Medicine

Electrolyte and hormonal disordersPain Management and Opioid Use

Cited by 41

Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom

Abrahami, D., D'Andrea, E., Yin, H., Kim, S. C., Paik, J. M., Wexler, D., Azoulay, L., & Patorno, E. (2023) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 39